Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study Meeting Abstract
| Authors: | Falchi, L.; Okwali, M.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Palomba, M. L.; Kumar, A.; Torka, P.; Leslie, L. A.; Ferreira Lopes, A.; Martinova, A.; Wood, L.; Grieve, C.; Ramos Amador, W.; Vardhana, S. A.; Zelenetz, A. D.; Salles, G. |
| Abstract Title: | Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 604 |
| Language: | English |
| ACCESSION: | WOS:001159306702117 |
| DOI: | 10.1182/blood-2023-179906 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- MSK author Alexandra Ferreira Lopes's last names reversed on publisher's record -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work